To the Editor:
Newly cloned interleukin 1 (IL-1) family members1,2,3 were originally given an IL-1 family (IL-1F) designation4, but as functions have now been elucidated for several of these5,6, we propose that each now be assigned an individual interleukin designation. IL-1F6, IL-1F8 and IL-1F9 are encoded by distinct genes but use the same receptor complex (IL-1Rrp2 and AcP), are proinflammatory and deliver nearly identical signals7,8,9,10,11,12. We propose these be designated IL-36α, IL-36β and IL-36γ, respectively. IL-1F5 also binds to IL-1Rrp2 but antagonizes those cytokines in a manner analogous to that used by IL-1Ra to antagonize IL-1α and IL-1β7,8,9. We propose that IL-1F5 be renamed IL-36Ra (for 'receptor antagonist'). In the IL-1 nomenclature, IL-1Ra is used for the natural product, whereas IL-1ra is used for the recombinant product; therefore, IL-36Ra is appropriate for natural IL-1F5.
IL-1F7 produces anti-inflammatory effects by suppressing innate immune responses; it does this by decreasing the production of inflammatory cytokines induced by Toll-like receptor agonists as well as that of IL-1 and tumor necrosis factor13,14. We propose this IL-1 family member be renamed IL-37. IL-1F7 has various splice forms1,2,15,16, of which IL-1F7b is the most studied. We propose that IL-1F7a, IL-1F7b and so on be renamed IL-37a, IL-37b and so on. The one remaining IL-1 family member, for which no function has yet been demonstrated, is IL-1F10; however, as evidence of its properties remains limited, we suggest that it retain its IL-1F designation until a function is clearly identified, although it might be prudent to reserve the designation IL-38 for this eventuality.
Change history
10 January 2011
In the version of this article initially published, the author name Peyman Kelk was inverted. The error has been corrected in the HTML and PDF versions of the article.
References
Smith, D.E. et al. J. Biol. Chem. 275, 1169–1175 (2000).
Kumar, S. et al. J. Biol. Chem. 275, 10308–10314 (2000).
Dunn, E., Sims, J.E., Nicklin, M.J. & O'Neill, L.A. Trends Immunol. 22, 533–536 (2001).
Sims, J.E. et al. Trends Immunol. 22, 536–537 (2001).
Dinarello, C.A. Annu. Rev. Immunol. 27, 519–550 (2009).
Sims, J.E. & Smith, D.E. Nat. Rev. Immunol. 10, 89–102 (2010).
Towne, J.E., Garka, K.E., Renshaw, B.R., Virca, G.D. & Sims, J.E. J. Biol. Chem. 279, 13677–13688 (2004).
Debets, R. et al. J. Immunol. 167, 1440–1446 (2001).
Blumberg, H. et al. J. Exp. Med. 204, 2603–2614 (2007).
Blumberg, H. et al. J. Immunol. 185, 4354–4362 (2010).
van Asseldonk, E.J.P. et al. Obesity (published online, doi:10.1038/oby.2010.55 (18 March 2010).
Magne, D. et al. Arthritis Res. Ther. 8, R80 (2006).
Sharma, S. et al. J. Immunol. 180, 5477–5482 (2008).
Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Bufler, P. & Dinarello, C.A. Nat. Immunol. 11, 1014–1022 (2010).
Busfield, S.J. et al. Genomics 66, 213–216 (2000).
Pan, G. et al. Cytokine 13, 1–7 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dinarello, C., Arend, W., Sims, J. et al. IL-1 family nomenclature. Nat Immunol 11, 973 (2010). https://doi.org/10.1038/ni1110-973
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1110-973
This article is cited by
-
The gasdermin protein family: emerging roles in gastrointestinal health and disease
Nature Reviews Gastroenterology & Hepatology (2023)
-
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease
Journal of Gastroenterology (2023)
-
Elevation of serum interleukin-1β levels as a potential indicator for malarial infection and severe malaria: a meta-analysis
Malaria Journal (2022)
-
Neutrophil extracellular traps are involved in enhanced contact hypersensitivity response in IL-36 receptor antagonist-deficient mice
Scientific Reports (2022)
-
Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction
Signal Transduction and Targeted Therapy (2022)